2 recruiting. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Recruiting 2 |
Follow Autoimmune: new trials by email Literature Review of Autoimmune trials Research Report on Autoimmune
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of JANX011 in Healthy Adult Volunteers to Assess Safety and Tolerability. JANX011 - Autoimmune | Early Phase 1 | Recruiting | Janux Therapeutics | 60 | 2026-02-16 | 2026-04-23 |
| A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of NEUK203-215 Injection in Adult Chinese Patients With Relapsed/Refractory Autoimmune Diseases Fludarabine, Cyclophosphamide (C), NEUK203-215 Injection - Autoimmune | Early Phase 1 | Recruiting | Neukio Biotherapeutics (Shanghai) Co., Ltd. | 8 | 2025-09-04 | 2026-07-15 |
Cyclophosphamide (1) · fludarabine (1)
Janux Therapeutics (1) · Neukio Biotherapeutics (Shanghai) Co., Ltd. (1)
Australia (1) · China (1)